All In Biotech

Drug Trial Radar · NCT00413218

Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections

Last checked: Nov 20, 2026Latest source record: Dec 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

450

Actual

Start

Mar 8, 2007

Primary completion

Mar 3, 2015

Study completion Mar 3, 2015

Sponsor

Lead sponsor
Astellas Pharma IncAstellas (ALPMY)
Sponsor type
Industry
Collaborators
Basilea Pharmaceutica
First posted
Dec 19, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to compare the safety and efficacy of isavuconazole versus caspofungin followed by voriconazole in the treatment of candidemia and other invasive Candida infections.

Conditions

  • Candidiasis, Invasive
  • Candidemia
  • Mycoses

Interventions

  • IsavuconazoleDrug

    Administered by intravenous infusion.

  • CaspofunginDrug

    Administered by intravenous infusion.

  • VoriconazoleDrug

    Administered by intravenous infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Overall Response of Success at the End of Intravenous Therapy (EOIV) as Determined by the Data Review Committee (DRC) Based on the Assessments of Clinical and Mycological Responses as Well as Alternative Systemic AFT UseTime frame: End of Intravenous Treatment (EOIV) (Days 11-56)

Locations

113 sites in 25 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Somero Research Corporation

    Palm Desert, California

  • University of California Davis Health System

    Sacramento, California

  • University of California at San Francisco

    San Francisco, California

  • Idaho Falls Infectious Diseases PLLC

    Idaho Falls, Idaho

  • Loyola University Hospital

    Maywood, Illinois

  • Springfield Clinic LLP

    Springfield, Illinois

  • Infectious Disease of Indiana

    Indianapolis, Indiana

  • Ochsner Clinic Foundation

    New Orleans, Louisiana

  • University of Maryland School of Medicine

    Baltimore, Maryland

  • UMASS Memorial Medical Center

    Worcester, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Mercury Street Medical Group

    Butte, Montana

  • Jersey Shore University Medical Center

    Neptune City, New Jersey

  • New York Presbyterian Hospital

    New York, New York

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina

  • Regional Infection Diseases Infusion Center Inc.

    Lima, Ohio

  • Temple University Health Sciences

    Philadelphia, Pennsylvania

  • Hospital Britanico de Buenos Aires

    Capital Federal, Argentina

  • Hospital General de Agudos Dr. Carlos G. Durand

    Capital Federal, Argentina

  • Hospital Italiano de Buenos Aires

    Ciudad Autonoma, Argentina

  • Instituto Medico Especializado Alexander Fleming

    Ciudad Autonoma, Argentina

  • Hospital General de Agudos Dr. Cosme Argerich

    La Boca, Argentina

  • Fremantle Hospital

    Fremantle, Australia

  • Mater Adult Hospital

    South Brisbane, Australia

  • Westmead Hospital

    Westmead, Australia

  • Princess Alexandra Hospital

    Woolloongabba, Australia

  • Institut Jules Bordet

    Brussels, Belgium

  • ULB Hôpital Erasme

    Brussels, Belgium

  • Universitair Ziekenhuis Brussel

    Brussels, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Universitaire Ziekenhuizen Leuven

    Leuven, Belgium

  • Hospital Felicio Rocho

    Belo Horizonte, Brazil

  • Hospital das Clinicas da Universidade Federal de Minas Gerai

    Belo Horizonte, Brazil

  • Santa Casa de Misericordia de Belo Horizonte

    Belo Horizonte, Brazil

  • Hospital das Clinicas da UFPR

    Curitiba, Brazil

  • Hospital Nossa Senhora das Gracas

    Curitiba, Brazil

  • Hospital Sao Lucas - PUCRS

    Porto Alegre, Brazil

  • Irmandade da Santa Casa de Misericordia de Porto Alegre

    Porto Alegre, Brazil

  • Hospital Universitario Clementino Fraga Filho

    Rio de Janeiro, Brazil

Showing 40 of 113 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.